Detalhe da pesquisa
1.
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study).
Breast Cancer Res
; 21(1): 100, 2019 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477168
2.
Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods.
Cancer
; 123(1): 114-121, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27571243
3.
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.
Breast Cancer Res
; 18(1): 6, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757880
4.
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Breast Cancer Res Treat
; 155(1): 139-49, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26667234
5.
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Breast Cancer Res
; 17: 25, 2015 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849745
6.
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.
Stem Cells
; 32(9): 2309-23, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24809620
7.
Dual HER2 blockade: preclinical and clinical data.
Breast Cancer Res
; 16(4): 419, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25928889
8.
The Enderstruder: An accessible open-source syringe extruder compatible with Ender series 3D printers.
HardwareX
; 17: e00510, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327675
9.
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
Sci Transl Med
; 13(624): eabj5070, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910551
10.
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.
Mol Cancer
; 9: 180, 2010 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615238
11.
Erratum: Dual HER2 blockade: preclinical and clinical data.
Breast Cancer Res
; 16(6): 468, 2014 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25927825
12.
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.
J Clin Oncol
; : JCO1800328, 2018 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339520
13.
Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Clin Breast Cancer
; 13(2): 133-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246269
14.
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.
Clin Cancer Res
; 19(10): 2723-33, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23549873
15.
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.
J Clin Oncol
; 31(14): 1726-31, 2013 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23569315